Lyra Therapeutics (LYRA) Cash & Equivalents (2019 - 2025)
Quarterly Cash & Equivalents fell 60.83% to $15.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $15.9 million through Dec 2025, down 60.83% year-over-year, with the annual reading at $15.9 million for FY2025, 60.83% down from the prior year.
Lyra Therapeutics' Cash & Equivalents history spans 7 years, with the latest figure at $15.9 million for Q4 2025.
- Cash & Equivalents came in at $15.9 million for Q4 2025, down from $22.1 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $122.1 million in Q2 2022 to a low of $15.9 million in Q4 2025.
- The 5-year median for Cash & Equivalents is $32.8 million (2024), against an average of $42.4 million.
- Year-over-year, Cash & Equivalents tumbled 76.35% in 2023 and then skyrocketed 78.38% in 2025.
- Lyra Therapeutics' Cash & Equivalents stood at $46.1 million in 2021, then decreased by 26.33% to $33.9 million in 2022, then crashed by 30.04% to $23.7 million in 2023, then surged by 70.89% to $40.6 million in 2024, then plummeted by 60.83% to $15.9 million in 2025.
- Per Business Quant, the three most recent readings for LYRA's Cash & Equivalents are $15.9 million (Q4 2025), $22.1 million (Q3 2025), and $29.8 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 1.91 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 32.30 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 901.90 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 61.46 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 2.77 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 5.49 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 2.96 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 18.44 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 1.71 Bn |
| 10 | Lyra Therapeutics | - | - | - | 15.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 15.89 Mn |
| Sep 30, 2025 | 22.06 Mn |
| Jun 30, 2025 | 29.78 Mn |
| Mar 31, 2025 | 31.74 Mn |
| Dec 31, 2024 | 40.58 Mn |
| Sep 30, 2024 | 25.79 Mn |
| Jun 30, 2024 | 33.90 Mn |
| Mar 31, 2024 | 17.79 Mn |
| Dec 31, 2023 | 23.75 Mn |
| Sep 30, 2023 | 26.24 Mn |
| Jun 30, 2023 | 55.75 Mn |
| Mar 31, 2023 | 23.41 Mn |
| Dec 31, 2022 | 33.94 Mn |
| Sep 30, 2022 | 110.98 Mn |
| Jun 30, 2022 | 122.09 Mn |
| Mar 31, 2022 | 34.08 Mn |
| Dec 31, 2021 | 46.08 Mn |
| Jun 30, 2021 | 69.05 Mn |
| Dec 31, 2020 | 74.92 Mn |
| Jun 30, 2020 | 86.60 Mn |
| Mar 31, 2020 | 35.25 Mn |
| Dec 31, 2019 | 9.81 Mn |